Dae-Sung Kim
Direttore/Membro del Consiglio presso Great Orient Chemical Pte Ltd.
Profilo
Dae-Sung Kim is currently a Director at Great Orient Chemical Pte Ltd.
and an Auditor at ID Biochem, Inc. He was previously the Chief Executive Officer & Director at ISU Abxis Co., Ltd.
from 2014 to 2017, Director, Executive Director & Director-Finance at ISU CHEMICAL CO., LTD.
from 2011 to 2012, and Director & Vice President at ISU Petasys Co., Ltd.
He obtained an undergraduate degree from Seoul National University.
Posizioni attive di Dae-Sung Kim
| Società | Posizione | Inizio |
|---|---|---|
ID Biochem, Inc.
 ID Biochem, Inc. Chemicals: SpecialtyProcess Industries Part of Pharmicell Co., Ltd., ID Biochem, Inc. is a South Korean company based in Ulsan, South Korea. The company specializes in the production of pharmaceuticals, including vaccines, anti-cancer drugs, and stem cell therapies. In 2012, ID Biochem was acquired by Pharmicell Co., Ltd. for $19.28 million. | Comptroller/Controller/Auditor | - |
| Great Orient Chemical Pte Ltd. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Dae-Sung Kim
| Società | Posizione | Fine |
|---|---|---|
| ISU ABXIS CO., LTD. | Amministratore Delegato | 24/03/2017 |
| ISU PETASYS CO., LTD. | Direttore/Membro del Consiglio | - |
| ISU CHEMICAL CO., LTD | Direttore Finanziario/CFO | - |
Formazione di Dae-Sung Kim
| Seoul National University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| ISU CHEMICAL CO., LTD | Process Industries |
| ISU PETASYS CO., LTD. | Electronic Technology |
| ISU ABXIS CO., LTD. | Health Technology |
| Aziende private | 2 |
|---|---|
ID Biochem, Inc.
ID Biochem, Inc. Chemicals: SpecialtyProcess Industries Part of Pharmicell Co., Ltd., ID Biochem, Inc. is a South Korean company based in Ulsan, South Korea. The company specializes in the production of pharmaceuticals, including vaccines, anti-cancer drugs, and stem cell therapies. In 2012, ID Biochem was acquired by Pharmicell Co., Ltd. for $19.28 million. | Process Industries |
| Great Orient Chemical Pte Ltd. |
- Borsa valori
- Insiders
- Dae-Sung Kim
